Orient Pharma Co., Ltd. (TPEX:4166)
Taiwan
· Delayed Price · Currency is TWD 23.30
-1.40 (-5.67%)
Mar 9, 2026, 1:30 PM CST
Orient Pharma Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 5,663 | 8,029 | 4,461 | 3,908 | 3,497 | 2,721 | Upgrade
|
| Market Cap Growth | -33.45% | 80.00% | 14.13% | 11.77% | 28.52% | 20.11% | Upgrade
|
| Enterprise Value | 5,318 | 8,510 | 5,080 | 4,148 | 3,763 | 3,110 | Upgrade
|
| Last Close Price | 23.30 | 36.00 | 20.00 | 20.90 | 18.70 | 14.55 | Upgrade
|
| PE Ratio | 41.03 | 74.78 | 200.14 | - | - | - | Upgrade
|
| PS Ratio | 4.43 | 6.57 | 5.01 | 7.64 | 7.55 | 6.60 | Upgrade
|
| PB Ratio | 2.29 | 4.49 | 2.67 | 3.59 | 3.13 | 2.24 | Upgrade
|
| P/TBV Ratio | 2.77 | 6.10 | 3.92 | 3.63 | 3.17 | 2.28 | Upgrade
|
| P/FCF Ratio | 20.59 | 47.32 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 17.82 | 40.76 | - | 343.32 | - | - | Upgrade
|
| EV/Sales Ratio | 4.16 | 6.96 | 5.71 | 8.10 | 8.12 | 7.55 | Upgrade
|
| EV/EBITDA Ratio | 16.46 | 31.21 | 36.55 | 333.67 | - | - | Upgrade
|
| EV/EBIT Ratio | 28.03 | 53.89 | 208.88 | - | - | - | Upgrade
|
| EV/FCF Ratio | 19.34 | 50.16 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.08 | 0.31 | 0.43 | 0.47 | 0.37 | 0.27 | Upgrade
|
| Debt / EBITDA Ratio | 0.62 | 1.87 | 4.52 | 20.74 | - | - | Upgrade
|
| Debt / FCF Ratio | 0.73 | 3.22 | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.14 | 0.25 | 0.36 | 0.38 | 0.24 | 0.11 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.13 | 1.60 | 4.35 | 33.06 | -3.20 | -1.17 | Upgrade
|
| Net Debt / FCF Ratio | -1.25 | 2.58 | -3.84 | -24.15 | -2.19 | -0.60 | Upgrade
|
| Asset Turnover | - | 0.48 | 0.40 | 0.28 | 0.26 | 0.25 | Upgrade
|
| Inventory Turnover | - | 2.23 | 1.97 | 2.03 | 2.17 | 2.67 | Upgrade
|
| Quick Ratio | 3.58 | 0.82 | 0.53 | 0.51 | 0.55 | 1.08 | Upgrade
|
| Current Ratio | 5.33 | 1.50 | 1.11 | 1.21 | 1.05 | 1.73 | Upgrade
|
| Return on Equity (ROE) | - | 6.21% | 1.62% | -2.61% | -8.80% | -15.56% | Upgrade
|
| Return on Assets (ROA) | - | 3.88% | 0.69% | -1.44% | -4.76% | -6.30% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.33% | 4.62% | 1.25% | -2.90% | -9.78% | -12.61% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.10% | 7.80% | 1.20% | -2.80% | -9.90% | -11.20% | Upgrade
|
| Earnings Yield | 2.26% | 1.34% | 0.50% | -0.74% | -2.94% | -6.30% | Upgrade
|
| FCF Yield | 4.86% | 2.11% | -3.52% | -0.43% | -3.43% | -8.17% | Upgrade
|
| Buyback Yield / Dilution | -1.06% | - | -19.27% | 0.00% | -10.40% | -8.57% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.